首页> 外文会议>International Conference on Pattern Recognition and Machine Intelligence >MaER: A New Ensemble Based Multiclass Classifier for Binding Activity Prediction of HLA Class II Proteins
【24h】

MaER: A New Ensemble Based Multiclass Classifier for Binding Activity Prediction of HLA Class II Proteins

机译:MAER:一种基于新的基于组合的多键分类器,用于HLA II类蛋白的结合活动预测

获取原文

摘要

Human Leukocyte Antigen class II (HLA II) proteins are crucial for the activation of adaptive immune response. In HLA class II molecules, high rate of polymorphisms has been observed. Hence, the accurate prediction of HLA II-peptide interactions is a challenging task that can both improve the understanding of immunological processes and facilitate decision-making in vaccine design. In this regard, during the last decade various computational tools have been developed, which were mainly focused on the binding activity prediction of different HLA II isotypes (such as DP, DQ and DR) separately. This fact motivated us to make a humble contribution towards the prediction of isotypes binding propensity as a multiclass classification task. In this regard, we have analysed a binding affinity dataset, which contains the interactions of 27 HLA II proteins with 636 variable length peptides, in order to prepare new multiclass datasets for strong and weak binding peptides. Thereafter, a new ensemble based multiclass classifier, called MetaEnsembleR (MaER) is proposed to predict the activity of weak/unknown binding peptides, by integrating the results of various heterogeneous classifiers. It pre-processes the training and testing datasets by making feature subsets, bootstrap samples and creates diverse datasets using principle component analysis, which are then used to train and test the MaER. The performance of MaER with respect to other existing state-of-the-art classifiers, has been estimated using validity measures, ROC curves and gain value analysis. Finally, a statistical test called Friedman test has been conducted to judge the statistical significance of the results produced by MaER.
机译:人白细胞抗原类II(HLA II)蛋白质对于激活适应性免疫应答至关重要。在HLA II类分子中,已经观察到高速率的多态性。因此,HLA II-肽相互作用的准确预测是一个具有挑战性的任务,可以改善对免疫过程的理解,并促进疫苗设计中的决策。在这方面,在过去十年中,已经开发了各种计算工具,主要集中在不同HLA II同学(例如DP,DQ和DR)的结合活性预测。这一事实激励我们对朝着多标量分类任务预测同种型倾向的谦逊贡献。在这方面,我们已经分析了结合亲和数据集,其含有27 HLA II蛋白的相互作用,其中具有636个可变长度肽,以便为强且弱的结合肽制备新的多种多数数据集。此后,提出了一种新的基于组合的多标量分类器,称为Metaensembler(MAER),以通过整合各种异质分类器的结果来预测弱/未知结合肽的活性。它通过制作功能子集,自举样本和使用原理分量分析创建不同的数据集来预先处理训练和测试数据集,然后使用原理分量分析来培训和测试MAER。 MAER关于其他现有最先进的分类器的性能,估计了使用有效性测量,ROC曲线和增益值分析。最后,已经进行了一种统计检验,已经进行了统计测试,以判断MAER产生的结果的统计学意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号